<DOC>
	<DOCNO>NCT00269412</DOCNO>
	<brief_summary>This placebo-controlled study three rifaximin dose patient DIBS . Subjects randomize receive daily dos placebo BID , rifaximin 275 mg BID , rifaximin 550 mg BID , 1100 mg BID 14 day . These four group subsequently receive additional two week placebo total 4 week treatment . A fifth group subject receive rifaximin 550 mg BID period 28 day . Subjects successfully respond treatment end 28-day Treatment Phase follow Post-treatment Phase include study visit Weeks 6 , 8 , 12 16 . Subjects relapse Post-treatment Phase discontinue study .</brief_summary>
	<brief_title>Study Assess Efficacy Safety Rifaximin Administered BID Treatment Patients With Diarrhea-Associated Irritable Bowel Syndrome</brief_title>
	<detailed_description>While IBS one common chronic medical condition etiology IBS unknown . Although life-threatening illness , IBS consider serious condition substantial impact subject 's day-to-day function . IBS characterize abdominal pain alter bowel habit , include diarrhea , constipation , alternate diarrhea constipation . Symptoms typically intermittent may continuous .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Rifaximin</mesh_term>
	<mesh_term>Rifamycins</mesh_term>
	<criteria>1 . Male female subject 18 year age old . 2 . Irritable bowel syndrome confirm Rome II Criteria 3 . Lower endoscopic examination demonstrate normal colonic anatomy 1 . Subject exclusively constipationpredominant IBS ( CIBS ) characterize &lt; 3 bowel movements/week hard lumpy stool . 2 . Subject alternate IBS , currently present constipation associate IBS symptom . 3 . Subject adequate control DIBS symptom bloat week precede screen visit time randomization . Bloating include follow symptom : abdominal fullness , bloating , gas , swell . 4 . Subjects positive stool culture O &amp; P ( ovum parasite ) and/or Clostridium difficile 5 . Subject fail record 2 negative weekly global assessment past 10 day prior randomization .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Irritable bowel syndrome</keyword>
</DOC>